(Adds details in paragraphs 2 and 3) Nov 16 (Reuters) – Incyte said on Monday the European Commission had approved its once-daily oral therapy for a type of chronic skin disease. The drug, Povofortay,
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
VIDEO SHOWS: MATCH POINT FROM THE FINAL OF THE ATP FINALS DOUBLES WON BY HENRY…
Nov 16 (Reuters) - User reports on Monday indicated problems at JPMorgan Chase, Bank of…
By Diana Novak Jones Nov 16 (Reuters) - California Attorney General Rob Bonta sued OpenAI on…
Nov 16 (Reuters) - PagSeguro Digital Ltd: * Q3 NET INCOME 584 MILLION REAIS VERSUS…
UKMTO: RECEIVED REPORT OF INCIDENT 7NM NORTH OF OMAN'S KHASAB (The article has been published…
By Stephen Culp and Utkarsh Hathi NEW YORK, Nov 16 (Reuters) - A broad selloff…